Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to supraclavicular block for pain after upper limb orthopedic surgery
IRCT20230409057864N2Phase 3Recruiting
- Sponsor
- Kerman University of Medical Sciences
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Pain intensity during surgery, Pain intensity in recovery and 4 more. Started Nov 2026; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20230409057864N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230409057864N2.